Internal Medicine, Hematology & Oncology · Miami, FL
NPI
1811336696
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
1475 NW 12th Ave
Miami, FL, 33136
Phone (305) 243-5302
Groups this clinician bills Medicare through
Medicare paid, 2024
$31K
295 services
Medicare patients, 2024
59
Average age 74
Drug cost, 2024
$2.3M
411 prescriptions
Company payments, 2025
$8,709
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Namrata Chandhok was code 99215 (office e&m - established), 179 times for 34 patients. In total Namrata Chandhok billed 295 services in 10 codes, and Medicare paid $31K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-09-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 179 | 34 | $114.22 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 86 | 21 | $98.54 | $8,475 |
| 99214 Office E&M - Established | Facility | 15 | 13 | $81.50 | $1,223 |
By year: 2022 $29K for 276 services; 2023 $43K for 401 services; 2024 $31K for 295 services.
Medicare prescription drug claims, 2024
In 2024, the drug Namrata Chandhok prescribed most often to Medicare patients was Levofloxacin, with 45 prescriptions and refills. In total Namrata Chandhok wrote 411 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levofloxacin Generic | 45 | 47 | 11 | $885 |
| Venclexta Venetoclax | 44 | 44 | 12 | $178K |
| Acyclovir Generic | 38 | 50 | 12 | $475 |
| Inqovi Decitabine/Cedazuridine | 33 | 33 | Under 11 | $273K |
| Imatinib Mesylate Generic | 29 | 30 | Under 11 | $36K |
| Ondansetron Hcl Generic | 24 | 24 | 11 | $163 |
| Pantoprazole Sodium Generic | 14 | 28 | Under 11 | $57.85 |
| Cresemba Isavuconazonium Sulfate | 14 | 14 | Under 11 | $80K |
| Onureg Azacitidine | 14 | 14 | Under 11 | $359K |
| Hydroxyurea Generic | 12 | 16 | Under 11 | $289 |
| Allopurinol Generic | 11 | 19 | Under 11 | $66.56 |
| Valacyclovir Valacyclovir Hcl | 11 | 11 | Under 11 | $720 |
Brand drugs: 149 claims; generic drugs: 262 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Namrata Chandhok $8,709 ($8,709 in general payments such as food, travel and fees) from 7 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $3,738.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.